Loading...

PE/Cyanine7 anti-mouse CD19 Antibody

Pricing & Availability
Clone
6D5 (See other available formats)
Regulatory Status
RUO
Other Names
B4
Isotype
Rat IgG2a, κ
Ave. Rating
Submit a Review
Product Citations
publications
6D5_PECyanine7_CD19_Antibody_1_071124
C57BL/6 mouse splenocytes were stained with anti-mouse CD3ε (clone 145-2C11) FITC and anti-mouse CD19 (clone 6D5) PE/Cyanine7 (left) or rat IgG2a, κ PE/Cyanine7 isotype control (right).
  • 6D5_PECyanine7_CD19_Antibody_1_071124
    C57BL/6 mouse splenocytes were stained with anti-mouse CD3ε (clone 145-2C11) FITC and anti-mouse CD19 (clone 6D5) PE/Cyanine7 (left) or rat IgG2a, κ PE/Cyanine7 isotype control (right).
Compare all formats See PE/Cyanine7 spectral data
Cat # Size Price Quantity Check Availability Save
115519 25 µg 62€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
115520 100 µg 172€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD19 is a 95 kD glycoprotein also known as B4. It is a member of the Ig superfamily, expressed on all pro-B to mature B cells (during development) and follicular dendritic cells. Plasma cells do not express CD19. CD19, in association with CD21 and CD81, forms a molecular complex integral to B cell activation.

Product Details
Technical data sheet

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Mouse CD19-expressing K562 human erythroleukemia cells
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PE/Cyanine7 under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

Additional reported applications (for the relevant formats) include: immunofluorescence7.

Application References

(PubMed link indicates BioLegend citation)
  1. Shoham T, et al. 2003. J. Immunol. 171:4062. (FC)
  2. Goodyear CS, et al. 2004. J. Immunol. 172:2870. (FC)
  3. Kamimura D, et al. 2006. J. Immunol. 177:306. (FC)
  4. Andoniou CE, et al. 2005. Nat. Immunol. 6:1011. (FC)
  5. Lawson BR, et al. 2007. J. Immunol. 178:5366. (FC)
  6. Phan TG, et al. 2007. Nat. Immunol. 8:992. (FC)
  7. Hayashida K, et al. 2008. J. Biol. Chem. 283:19895. (IF) PubMed
  8. Charles N, et al. 2010. Nat. Med. 16:701. (FC) PubMed
  9. Bankoti J, et al. 2010. Toxicol. Sci. 115:422. (FC) PubMed
  10. Stadnisky MD, et al. 2011. Blood. 117:5133. (FC) PubMed
  11. Perlot T, et al. 2012. J. Immunol. 188:1201. (FC) PubMed
  12. Olive V, et al. 2013. Elife. 2:822. PubMed
  13. Miyai T, et al. 2014. PNAS. 111:11780. PubMed
Product Citations
  1. Grigsby SM, et al. 2021. Cancers (Basel). 13:. PubMed
  2. Zhu Y, et al. 2022. Nat Commun. 13:4282. PubMed
  3. Friesen M, et al. 2022. Brain Pathol. 32:e13032. PubMed
  4. Omer-Javed A, et al. 2022. Cell. 185:2248. PubMed
  5. Millar FR, et al. 2022. Cell Rep. 41:111596. PubMed
  6. Zhang B, et al. 2023. Signal Transduct Target Ther. 8:28. PubMed
  7. Morse M, et al. 2016. Lupus. 25: 81 - 87. PubMed
  8. Barrett N, et al. 2016. Cell Rep. 16: 1039-1054. PubMed
  9. Bussières-Marmen S, et al. 2017. Cell Mol Immunol. 10.1038/cmi.2016.72. PubMed
  10. Turecamo SE, et al. 2018. Matrix Biol. 67:01:00. PubMed
  11. Agrafiotis A, et al. 2023. iScience. 26:106055. PubMed
  12. Wang Y, et al. 2023. EBioMedicine. 90:104480. PubMed
  13. Rundberg Nilsson A, et al. 2023. iScience. 26:106341. PubMed
  14. van Os BW, et al. 2023. Eur Heart J Open. 3:oead013. PubMed
  15. Prior JT, et al. 2023. NPJ Vaccines. 8:80. PubMed
  16. Schloss MJ, et al. 2022. Nat Immunol. 23:605. PubMed
  17. Lin YH, et al. 2021. Front Immunol. 12:626418. PubMed
  18. d'Errico P, et al. 2021. Nat Neurosci. Online ahead of print. PubMed
  19. Symeonidou V, et al. 2021. Cell Rep. 37:109900. PubMed
  20. Clark K, et al. 2015. J Autoimmun. Available online 21 August 2015. PubMed
  21. Castañeda-Zegarra S, et al. 2020. Aging (Albany NY). 12:00. PubMed
  22. Yu K, et al. 2021. Cell Reports. 35(12):109273. PubMed
  23. Yang C, et al. 2020. J Control Release. 326:324. PubMed
  24. Lin CA, et al. 2021. Pharmaceutics. 13:. PubMed
  25. Morgado P, et al. 2014. Infect Immun . 82:4047. PubMed
  26. Schiller M, et al. 2021. Immunity. 54(5):1022-1036.e8. PubMed
  27. Jtte BB, et al. 2021. iScience. 24(8):102833. PubMed
  28. Liao Y, et al. 2017. Virol J. 10.1186/s12985-017-0801-x. PubMed
  29. Alberti D, et al. 2021. Curr Protoc. 1:e311. PubMed
  30. Rogawski DS, et al. 2021. Nat Commun. 12:2792. PubMed
  31. Ma M, et al. 2021. Front Immunol. 12:718779. PubMed
  32. Paiva RS, et al. 2021. Eur J Immunol. 51:1968. PubMed
  33. Haugh KA, et al. 2021. eLife. 0.416666666666667. PubMed
  34. Campana L, et al. 2018. J Immunol. 200:1169. PubMed
  35. Sasaki K, et al. 2019. Nat Commun. 10:3878. PubMed
  36. Yoshida K, et al. 2022. Sci Rep. 12:17276. PubMed
  37. Wiesner D, et al. 2015. PLoS Pathog. 11:1004701. PubMed
  38. Syed A, et al. 2015. Infect Immun . 83: 3428-3437. PubMed
  39. Uchil PD et al. 2018. Cell host & microbe. 25(1):87-100 . PubMed
  40. Schaffert A, et al. 2020. Front Immunol. 10:3024. PubMed
  41. Calés C, et al. 2016. Mol Cell Biol. 36: 900 - 912. PubMed
  42. JI B, et al. 2016. Cell Death Differ. 23:759-75. PubMed
  43. Qi T, et al. 2020. Cell Rep. 33:108452. PubMed
  44. Derecka M, et al. 2020. Nat Immunol. 261:21. PubMed
  45. Pereira JA, et al. 2020. Hum Mol Genet. 29:1253. PubMed
  46. , et al. 2021. Eur J Immunol. 51:2708. PubMed
  47. Siggs O, et al. 2015. Proc Natl Acad Sci U S A. 112: E5706 - E5714. PubMed
  48. Frodermann V, et al. 2019. Nat Med. 25:1761. PubMed
  49. Bradley KC, et al. 2019. Cell Rep. 28:245. PubMed
  50. Malik A et al. 2018. Immunity. 49(3):515-530 . PubMed
  51. Noviski M, et al. 2018. Elife. 7:e35074. PubMed
  52. Zhang H, et al. 2019. Mol Cell. 76:110. PubMed
  53. Kräutler NJ, et al. 2020. Cell Reports. 30(4):997-1012.e6.. PubMed
  54. Wu S, et al. 2022. BMC Immunol. 23:17. PubMed
  55. Kang X, et al. 2022. J Immunol Res. 2022:8118577. PubMed
  56. Madenspacher JH, et al. 2020. JCI Insight. 5:00. PubMed
  57. Pillonel V, et al. 2016. Sci Rep. 6:37772. PubMed
  58. Lim S, et al. 2016. PLoS One. 11: 0155689. PubMed
  59. Challa TD, et al. 2020. Cell Reports. 30(10):3424-3433. PubMed
  60. Wang YH, et al. 2019. Front Immunol. 10:1909. PubMed
  61. Cohen M et al. 2018. Cell. 175(4):1031-1044 . PubMed
  62. Shiozawa S, et al. 2022. iScience. 25:103537. PubMed
  63. Ma K, et al. 2022. iScience. 25:104347. PubMed
  64. Zhang P, et al. 2022. Nat Commun. 13:1588. PubMed
  65. Kim MY, et al. 2018. Cell. 173:1439. PubMed
  66. Matthew B Buechler et al. 2019. Immunity. 51(1):119-130 . PubMed
  67. Li M, et al. 2021. Cancers (Basel). 13:. PubMed
  68. Wieghofer P, et al. 2021. EMBO J. 40:e105123. PubMed
  69. Zhou J, et al. 2022. Int J Oncol. 61: . PubMed
  70. Lehrke MJ, et al. 2021. Elife. 10:. PubMed
  71. Mandal RK, et al. 2021. Cell Reports. 35(6):109094. PubMed
  72. Zhou X, et al. 2021. Cell Reports. 34(1):108601. PubMed
  73. Haniuda K, et al. 2020. Cell Rep. 33:108333. PubMed
  74. Onai N, et al. 2020. Int J Mol Sci. :22. PubMed
  75. Andersen TK, et al. 2019. NPJ Vaccines. 4:9. PubMed
  76. Ackermann C, et al. 2019. Sci Rep. 9:10624. PubMed
  77. Willemsen J, et al. 2021. Cell Rep. 37:109977. PubMed
  78. Chen C, et al. 2020. Cell Rep. 2136:30. PubMed
  79. Baglaenko Y, et al. 2016. PLoS One. 11: 0150515. PubMed
  80. Vincent B, et al. 2010. J Immunol. 184:4196. PubMed
  81. Ghezraoui H, et al. 2018. Nature. 560:122. PubMed
  82. Korin B, et al. 2020. Sleep. :43. PubMed
  83. Shimba A et al. 2018. Immunity. 48(2):286-298 . PubMed
  84. Zhang Y, et al. 2022. Front Pharmacol. 13:952775. PubMed
  85. Boulch M, et al. 2021. Sci Immunol. 6:. PubMed
  86. Han P, et al. 2020. Sci Adv. 6:eaaz1580. PubMed
  87. Guo Y, et al. 2021. Nat Immunol. 22:746. PubMed
  88. Parigger T, et al. 2021. Int J Mol Sci. 22:. PubMed
  89. Rodrigues KA, et al. 2021. Sci Adv. 7:eabj6538. PubMed
  90. Bansal K, et al. 2017. Nat Immunol. 18:263-273. PubMed
  91. Leruste A, et al. 2020. Cancer Cell. 36(6):597-612.e8.. PubMed
  92. Song W, et al. 2022. Immunity. 55:290. PubMed
  93. Zhang B, et al. 2021. Front Neurol. 607370:12. PubMed
  94. Kleiman E, et al. 2016. Proc Natl Acad Sci U S A. 113: E3911 - E3920. PubMed
  95. Fusciello M, et al. 2019. Nat Commun. 4.407638889. PubMed
  96. Huang LH et al. 2018. Cell metabolism. 29(2):475-487 . PubMed
RRID
AB_313654 (BioLegend Cat. No. 115519)
AB_313654 (BioLegend Cat. No. 115520)

Antigen Details

Structure
Ig superfamily, associates with CD21 and CD81, 95 kD
Distribution

Pro-B cells to mature B cells (during development), follicular dendritic cells

Function
Modulates B cell activation and differentiation
Ligand/Receptor
CD21, CD81, Leu-13
Cell Type
B cells, Dendritic cells
Biology Area
Costimulatory Molecules, Immunology
Molecular Family
CD Molecules
Antigen References

1. Fearon DT. 1993. Curr. Opin. Immunol. 5:341.
2. Krop I, et al. 1996. Eur. J. Immunol. 26:238.
3. Krop I, et al. 1996. J. Immunol. 157:48.
4. Tedder TF, et al. 1994. Immunol. Today 15:437.

Gene ID
12478 View all products for this Gene ID
Specificity (DOES NOT SHOW ON TDS):
CD19
Specificity Alt (DOES NOT SHOW ON TDS):
CD19
App Abbreviation (DOES NOT SHOW ON TDS):
FC
UniProt
View information about CD19 on UniProt.org

Related FAQs

There are no FAQs for this product.

Other Formats

View All CD19 Reagents Request Custom Conjugation
Description Clone Applications
APC anti-mouse CD19 6D5 FC
Biotin anti-mouse CD19 6D5 FC
FITC anti-mouse CD19 6D5 FC
PE anti-mouse CD19 6D5 FC
PE/Cyanine5 anti-mouse CD19 6D5 FC
Purified anti-mouse CD19 6D5 FC,CyTOF®,IHC-F
PE/Cyanine7 anti-mouse CD19 6D5 FC
Alexa Fluor® 488 anti-mouse CD19 6D5 FC
Alexa Fluor® 647 anti-mouse CD19 6D5 FC,IHC-F
Pacific Blue™ anti-mouse CD19 6D5 FC
Alexa Fluor® 700 anti-mouse CD19 6D5 FC
APC/Cyanine7 anti-mouse CD19 6D5 FC
PerCP anti-mouse CD19 6D5 FC
PerCP/Cyanine5.5 anti-mouse CD19 6D5 FC
Alexa Fluor® 594 anti-mouse CD19 6D5 IHC-F,FC
Brilliant Violet 421™ anti-mouse CD19 6D5 FC,IHC-F
Brilliant Violet 570™ anti-mouse CD19 6D5 FC
Brilliant Violet 605™ anti-mouse CD19 6D5 FC
Brilliant Violet 650™ anti-mouse CD19 6D5 FC
Brilliant Violet 785™ anti-mouse CD19 6D5 FC
Brilliant Violet 510™ anti-mouse CD19 6D5 FC
Purified anti-mouse CD19 (Maxpar® Ready) 6D5 FC,CyTOF®
PE/Dazzle™ 594 anti-mouse CD19 6D5 FC
Brilliant Violet 711™ anti-mouse CD19 6D5 FC
APC/Fire™ 750 anti-mouse CD19 6D5 FC
TotalSeq™-A0093 anti-mouse CD19 6D5 PG
Brilliant Violet 750™ anti-mouse CD19 6D5 FC
TotalSeq™-B0093 anti-mouse CD19 6D5 PG
Spark Blue™ 550 anti-mouse CD19 6D5 FC
Spark NIR™ 685 anti-mouse CD19 6D5 FC
TotalSeq™-C0093 anti-mouse CD19 6D5 PG
Ultra-LEAF™ Purified anti-mouse CD19 6D5 FC,CyTOF®,IHC-F
PE/Fire™ 640 anti-mouse CD19 Antibody 6D5 FC
Spark YG™ 581 anti-mouse CD19 6D5 FC
APC/Fire™ 810 anti-mouse CD19 6D5 FC
Spark YG™ 570 anti-mouse CD19 6D5 IHC-F
Spark Blue™ 574 anti-mouse CD19 Antibody 6D5 FC
Spark Blue™ 515 anti-mouse CD19 6D5 FC
Spark UV™ 387 anti-mouse CD19 6D5 FC
Spark Red™ 718 anti-mouse CD19 (Flexi-Fluor™) 6D5 FC
Go To Top Version: 2    Revision Date: 05.24.2013

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account